Template:In the news: Difference between revisions
Jump to navigation
Jump to search
(Created page with "Star of life|right|thumb * [https://thehill.com/policy/healthcare/4962699-ozempic-wegovy-considered-available/ Ozempic and Wegovy considered ‘available’] after more than 2 years in shortage * [https://gizmodo.com/new-antibiotic-hits-the-market-to-tackle-stubborn-utis-2000517862 New antibiotic Orlynva] - It is the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs * [https://www.nytimes.com/2024/10/30/he...") |
No edit summary |
||
| Line 1: | Line 1: | ||
[[File:Star of life2.svg|Star of life| | [[File:Star of life2.svg|Star of life|400px|left]] | ||
* [https://thehill.com/policy/healthcare/4962699-ozempic-wegovy-considered-available/ Ozempic and Wegovy considered ‘available’] after more than 2 years in shortage | * [https://thehill.com/policy/healthcare/4962699-ozempic-wegovy-considered-available/ Ozempic and Wegovy considered ‘available’] after more than 2 years in shortage | ||
* [https://gizmodo.com/new-antibiotic-hits-the-market-to-tackle-stubborn-utis-2000517862 New antibiotic Orlynva] - It is the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs | * [https://gizmodo.com/new-antibiotic-hits-the-market-to-tackle-stubborn-utis-2000517862 New antibiotic Orlynva] - It is the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs | ||
* [https://www.nytimes.com/2024/10/30/health/ozempic-wegovy-knee-pain-osteoarthritis.html Ozempic and Wegovy shows promise in knee pain due to Osteoarthritis] | * [https://www.nytimes.com/2024/10/30/health/ozempic-wegovy-knee-pain-osteoarthritis.html Ozempic and Wegovy shows promise in knee pain due to Osteoarthritis] | ||
* [https://www.news-medical.net/news/20241030/AI-shows-promise-for-predicting-embryonic-health-without-invasive-testing.aspx AI shows promise for predicting embryonic health without invasive testing] | * [https://www.news-medical.net/news/20241030/AI-shows-promise-for-predicting-embryonic-health-without-invasive-testing.aspx AI shows promise for predicting embryonic health without invasive testing] | ||
Revision as of 03:40, 31 October 2024
- Ozempic and Wegovy considered ‘available’ after more than 2 years in shortage
- New antibiotic Orlynva - It is the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs
- Ozempic and Wegovy shows promise in knee pain due to Osteoarthritis
- AI shows promise for predicting embryonic health without invasive testing